Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Taylor, Catherine A ^a   Zheng, Qifa ^a   Liu, Zhongda ^a   Thompson, John E ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Apoptosis; eIF5A; Hypusine; MAPK; p53

Indexed keywords

ADENOVIRUS VECTOR; EUKARYOTIC TRANSLATION INITIATION FACTOR 5A1; INITIATION FACTOR 5A; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE, TUMOR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE INITIATION FACTORS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; EUKARYOTA;

EID: 84876863416     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-35     Document Type: Article

References (50)

1. Caraglia M, Park MH, Wolff EC, Marra M, Abbruzzese A. eIF5A isoforms and cancer: two brothers for two functions?. Amino Acids 2013, 44:103-109. 10.1007/s00726-011-1182-x, 3536922, 22139412.
2. Jenkins ZA, Hååg PG, Johansson HE. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 2001, 71:101-109. 10.1006/geno.2000.6418, 11161802.
3. Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Fang Y, Sham JS. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 2004, 64:4197-4200. 10.1158/0008-5472.CAN-03-3747, 15205331.
4. Tang DJ, Dong SS, Ma NF, Xie D, Chen L, Fu L, Lau SH, Li Y, Li Y, Guan XY. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology 2010, 51:1255-1263. 10.1002/hep.23451, 20112425.
5. Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 2008, 39:80-86. 10.1016/j.humpath.2007.05.011, 17949776.
6. Saini P, Eyler DE, Green R, Dever TE. Hypusine-containing protein eIF5A promotes translation elongation. Nature 2009, 459:118-121. 10.1038/nature08034, 3140696, 19424157.
7. Liu YP, Nemeroff M, Yan YP, Chen KY. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification. Biol Signals 1997, 6:166-174. 10.1159/000109123, 9285100.
8. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 2010, 120:2156-2170. 10.1172/JCI38924, 2877928, 20501948.
9. Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 1993, 4:95-104.
10. Moore CC, Martin EN, Lee G, Taylor C, Dondero R, Reznikov LL, Dinarello C, Thompson J, Scheld WM. Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury. J Infect Dis 2008, 198:1407-1414. 10.1086/592222, 2845286, 18793104.
11. Li A, Li HY, Jin BF, Ye QN, Zhou T, Yu XD, Pan X, Man JH, He K, Yu M, Hu MR, Wang J, Yang SC, Shen BF, Zhang XM. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 2004, 279:49251-49258. 10.1074/jbc.M407165200, 15371445.
12. Taylor CA, Senchyna M, Flanagan J, Joyce EM, Cliche DO, Boone AN, Culp-Stewart S, Thompson JE. Role of eIF5A in TNF-alpha-mediated apoptosis of lamina cribrosa cells. Invest Ophthalmol Vis Sci 2004, 45:3568-3576. 10.1167/iovs.03-1367, 15452064.
13. Taylor CA, Sun Z, Cliche DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE. Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling. Exp Cell Res 2007, 313:437-449. 10.1016/j.yexcr.2006.09.030, 17187778.
14. Jin S, Taylor CA, Liu Z, Sun Z, Ye B, Thompson JE. Suppression of primary and disseminated murine tumor growth with eIF5A1 gene therapy. Gene Ther Mol Biol 2008, 12:207-218.
15. Sun Z, Cheng Z, Taylor CA, McConkey BJ, Thompson JE. Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway. J Cell Physiol 2010, 223:798-809.
16. Taylor CA, Liu Z, Tang TC, Zheng Q, Francis S, Wang TW, Ye B, Lust JA, Dondero R, Thompson JE. Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma. Mol Ther 2012, 20:1305-1314. 10.1038/mt.2012.94, 22588272.
17. Tan X, Wang DB, Lu X, Wei H, Zhu R, Zhu SS, Jiang H, Yang ZJ. Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. Biol Pharm Bull 2010, 33:1666-1672. 10.1248/bpb.33.1666, 20930373.
18. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40. 10.1038/35065000, 11242034.
19. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001, 268:2764-2772. 10.1046/j.1432-1327.2001.02225.x, 11358490.
20. Ip Y, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 1998, 10:205-219. 10.1016/S0955-0674(98)80143-9, 9561845.
21. Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, Zhou W, Zheng Q, Wu M, Otterson GA, Zhu WG. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol 2006, 26:2782-2790. 10.1128/MCB.26.7.2782-2790.2006, 1430330, 16537920.
22. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334. 10.1016/S0092-8674(00)80416-X, 9363941.
23. Dumaz N, Meek DW. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 1999, 18:7002-7010. 10.1093/emboj/18.24.7002, 1171763, 10601022.
24. Sanchez-Prieto R, Rojas JM, Taya Y, Gutkind JS. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res 2000, 60:2464-2472.
25. She QB, Chen N, Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem 2000, 275:20444-20449. 10.1074/jbc.M001020200, 10781582.
26. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299. 10.1016/0092-8674(95)90412-3, 7834749.
27. Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002, 4:842-849. 10.1038/ncb866, 12402042.
28. Clement PM, Johansson HE, Wolff EC, Park MH. Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J 2006, 273:1102-1114. 10.1111/j.1742-4658.2006.05135.x, 16519677.
29. Ley R, Ewings KE, Hadfield K, Howes E, Balmanno K, Cook SJ. Extracellular signal regulated kinases 1/2 are serum-stimulated " Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem 2004, 279:8837-8847. 10.1074/jbc.M311578200, 14681225.
30. Ewings KE, Hadfield-Moorhouse K, Wiggins CM, Wickenden JA, Balmanno K, Gilley R, Degenhardt K, White E, Cook SJ. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J 2007, 26:2856-2867. 10.1038/sj.emboj.7601723, 1894764, 17525735.
31. Persons DL, Yazlovitskaya EM, Pelling JC. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 2000, 275:35778-35785. 10.1074/jbc.M004267200, 10958792.
32. Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, Jung JS, Kim JM. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 2005, 25:374-382. 10.1002/jat.1081, 16013042.
33. Butterfield L, Storey B, Maas L, Heasley LE. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 1997, 272:10110-10116. 10.1074/jbc.272.15.10110, 9092556.
34. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997, 272:22173-22181. 10.1074/jbc.272.35.22173, 9268362.
35. Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono K, Tsuruo T. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 1999, 18:173-180. 10.1038/sj.onc.1202276, 9926932.
36. Behrens A, Sibilia M, Wagner EF. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 1999, 21:326-329. 10.1038/6854, 10080190.
37. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991, 353:670-674. 10.1038/353670a0, 1922387.
38. Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003, 22:3876-3886. 10.1093/emboj/cdg388, 169061, 12881422.
39. Humar M, Loop T, Schmidt R, Hoetzel A, Roesslein M, Andriopoulos N, Pahl HL, Geiger KK, Pannen BH. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Int J Biochem Cell Biol 2007, 39:2278-2288. 10.1016/j.biocel.2007.06.013, 17689131.
40. Bean LJ, Stark GR. Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene 2001, 20:1076-1084. 10.1038/sj.onc.1204204, 11314044.
41. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999, 18:3205-3212. 10.1038/sj.onc.1202656, 10359526.
42. Amano T, Nakamizo A, Mishra SK, Gumin J, Shinojima N, Sawaya R, Lang FF. Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes. J Neurooncol 2009, 92:357-371. 10.1007/s11060-009-9844-1, 19357962.
43. Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella ED. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 1997, 36:10117-10124. 10.1021/bi970759w, 9254608.
44. Wu GS. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 2004, 3:156-161.
45. Sax JK, El-Deiry WS. p53 downstream targets and chemosensitivity. Cell Death Differ 2003, 10:413-417. 10.1038/sj.cdd.4401227, 12719718.
46. Scuoppo C, Miething C, Lindqvist L, Reyes J, Ruse C, Appelmann I, Yoon S, Krasnitz A, Teruya-Feldstein J, Pappin D, Pelletier J, Lowe SW. A tumour suppressor network relying on the polyamine-hypusine axis. Nature 2012, 487:244-248. 10.1038/nature11126, 3530829, 22722845.
47. König HG, Rehm M, Gudorf D, Krajewski S, Gross A, Ward MW, Prehn JH. Full length Bid is sufficient to induce apoptosis of cultured rat hippocampal neurons. BMC Cell Biol 2007, 8:7. 10.1186/1471-2121-8-7, 1808451, 17326836.
48. Pei Y, Xing D, Gao X, Liu L, Chen T. Real-time monitoring full length bid interacting with Bax during TNF-alpha-induced apoptosis. Apoptosis 2007, 12:1681-1690. 10.1007/s10495-007-0091-7, 17520191.
49. Eskes R, Desagher S, Antonsson B, Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 2000, 20:929-935. 10.1128/MCB.20.3.929-935.2000, 85210, 10629050.
50. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001, 21:6913-6926. 10.1128/MCB.21.20.6913-6926.2001, 99868, 11564875.